• Dépistage, diagnostic, pronostic

  • Essais de technologies et de biomarqueurs dans un contexte clinique

  • Col de l'utérus

Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines

Menée à partir de données portant au total sur 17 337 adolescentes ou jeunes femmes new-yorkaises à faible revenu et issues de minorités ethniques (âge : 13 à 20 ans durant la période 2007-2009 ou la période 2009-2012), cette étude évalue l'évolution de l'utilisation du test de Papanicolaou après la publication en 2009 de recommandations sur le dépistage du cancer du col de l'utérus, puis identifie les facteurs prédictifs associés à un dépistage avant 21 ans

Objectives : In December 2009, the American College of Obstetricians and Gynecologists recommended that cervical cancer screening begin at age 21 for young women. In this study, we examine receipt of the first lifetime Papanicolaou (Pap) test and predictors of over-screening among adolescents within a large urban ambulatory care network.

Methods : We compared the proportion of the first lifetime Pap test of adolescents aged 13–20 years between June 2007 and November 2009 (n = 7700) and December 2009–June 2012 (n = 9637) using electronic health records. We employed multivariable regression models to identify demographic and health care factors associated with receiving a first lifetime Pap test at age < 21 years in the post-guideline period (over-screening).

Results : The proportion of Pap tests declined from 19.3% to 4.2% (p < 0.001) between the two periods. Multivariable logistic regression results showed receiving care from gynecologic/obstetric/family planning clinics compared to pediatric clinics, having more clinic encounters, and older age were associated with over-screening in the post-guideline period.

Conclusions : We found that guideline adherence differed by clinic type, insurance status, and health care encounters. In the quickly evolving field of cervical cancer control, it is important to monitor practice trends as they relate to shifts in population-based guidelines, especially in high-risk populations.

Preventive Medicine , résumé, 2013

Voir le bulletin